ArticleCancers2026

Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer.

Akshara Singareeka Raghavendra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.